Research on the impact of managed care on access, quality, outcomes, a
nd costs of mental health and substance abuse services has been limite
d because of the lack of generalizability of studies, the ''black box'
' focus of much of the research, the dynamic changes in mental health
and substance abuse managed care, and the proprietary nature of the he
alth care industry. This article provides a framework for understandin
g the organizational, financial, and procedural features of health pla
ns and the effect of these features on the characteristics and flow of
patients through health plans and the selection and utilization of tr
eatments. The diverse research priorities of key stakeholders, ie, pub
lic and private purchasers, managed care organizations, providers, and
patients and their families, are described along with a broader socie
tal agenda for delineating the outcomes of health care plans. Critical
research and methodologic issues in studying the effects of managed c
are are outlined, including issues related to identifying and selectin
g appropriate outcome measures and developing appropriate methods for
risk adjustment to adequately control for patient selection bias. This
article asserts that government, purchasers, health care plans, provi
ders, consumers, and researchers must collaboratively develop resource
s and research approaches to fully evaluate the effects of managed car
e. To realize this objective, auspices with reasonable objectivity are
needed along with access to necessary data within the black box of he
alth care systems, a cadre of trained investigators, and sufficient re
search funding, including the development of an all payers fund to sup
port clinical and health services research.